Companies Elevance Health
Elevance Health (ELV): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Elevance Health’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO vs. named peers32nd pct.Of 40 peer CEOs
CEO pay, last three years
- $21,889,039FY2023
- $20,471,976FY2024
- $22,582,314FY2025
CEO total pay was $22,582,314 in fiscal 2025, up from $20,471,976 in fiscal 2024.
FY2025: salary $1,600,000 · bonus $0 · stock awards $13,440,277 · option awards $4,199,765
Executives and directors
Peter Haytaian · EVPGail Boudreaux · CEOC. Morgan Kendrick · EVPMark Kaye · CFOFelicia Norwood · EVPAmy W. Schulman · Independent DirectorAntonio F. Neri · Independent DirectorBahija Jallal · Independent DirectorDeanna D. Strable · Independent DirectorElizabeth E. Tallett · Former director (through FY2025)Lewis Hay III · Independent DirectorR. Kerry Clark · Independent DirectorRamiro G. Peru · Chair of the BoardRobert L. Dixon Jr · Independent DirectorRyan M. Schneider · Independent DirectorSteven H. Collis · Independent DirectorSusan D. DeVore · Independent Director
Frequently asked questions
Who was the highest-paid executive at Elevance Health in fiscal 2025?
As disclosed, Gail Boudreaux (President and Chief Executive Officer) was the highest-paid executive at Elevance Health in fiscal 2025, with total compensation of $22,582,314.
How does Elevance Health's chief executive pay compare to its disclosed peer group?
As disclosed, Gail Boudreaux's total compensation ranked at the 32nd percentile of Elevance Health's disclosed peer group.
What is Elevance Health's CEO-to-median employee pay ratio?
As disclosed, Elevance Health's CEO-to-median employee pay ratio was 286:1.
How did shareholders vote on Elevance Health's executive compensation?
As disclosed, 95.97% of shareholders supported Elevance Health's executive compensation in the latest say-on-pay vote.
How much does Elevance Health spend in total on board compensation for fiscal 2025?
As disclosed, Elevance Health reported total board compensation of $4,218,691 for fiscal 2025.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Gail Boudreaux | $1,600,000 | $0 | $13,440,277 | $4,199,765 | $2,768,000 | $0 | $574,272 | $22,582,314 |
| President and Chief Executive Officer | ||||||||
| Mark Kaye | 938,462 | 0 | 4,560,511 | 1,424,506 | 974,123 | 0 | 94,475 | 7,992,077 |
| Executive Vice President and Chief Financial Officer | ||||||||
| Peter Haytaian | 950,000 | 0 | 3,840,306 | 1,199,710 | 986,100 | 0 | 122,372 | 7,098,488 |
| Executive Vice President and President of Carelon and CarelonRx | ||||||||
| Felicia Norwood | 950,000 | 0 | 3,840,306 | 1,199,710 | 986,100 | 0 | 97,849 | 7,073,965 |
| Executive Vice President and President of Government Health Benefits | ||||||||
| C. Morgan Kendrick | 888,462 | 0 | 3,600,237 | 1,124,813 | 922,223 | 23,417 | 102,759 | 6,661,911 |
| Executive Vice President and President of Commercial and Specialty Health Benefits | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Gail Boudreaux | $22,582,314 | $20,471,976 | $21,889,039 | ↑ +2,110,338 |
| Mark Kaye | 7,992,077 | 6,873,144 | 12,359,201 | ↑ +1,118,933 |
| Peter Haytaian | 7,098,488 | 6,345,127 | 6,978,051 | ↑ +753,361 |
| Felicia Norwood | 7,073,965 | 6,288,946 | 6,475,408 | ↑ +785,019 |
| C. Morgan Kendrick | 6,661,911 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
Our executive compensation program, which we refer to as Total Rewards, is designed to: Attract, engage, motivate, retain and appropriately reward executives for their contributions to our business, our consumers, our associates and our shareholders. Closely align executive interests and rewards with the interests of our shareholders. Demonstrate the commitment of our Company and our Board to integrate the interests of our stakeholders (consumers, shareholders, providers and associates) with our practices and executive rewards. Drive the achievement of the Company's purpose, values and strategy. Deliver compensation that is commensurate with Company and individual performance within the context of the external market.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Willis Towers Watson (WTW) |
| Clawback policy | True |
| Anti-hedging | True |
| Anti-pledging | True |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2025
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| C. Morgan Kendrick | PSU | 2025-03-03 | 0 | 6,258 | — | 12,516 | $2,475,039 |
| Felicia Norwood | PSU | 2025-03-03 | 0 | 6,675 | — | 13,350 | 2,639,963 |
| Gail Boudreaux | PSU | 2025-03-03 | 0 | 23,363 | — | 46,726 | 9,240,067 |
| Peter Haytaian | PSU | 2025-03-03 | 0 | 6,675 | — | 13,350 | 2,639,963 |
| Mark Kaye | PSU | 2025-03-03 | 0 | 7,927 | — | 15,854 | 3,135,129 |
| Gail Boudreaux | RSU | 2025-03-03 | — | — | 10,620 | — | 4,200,210 |
| C. Morgan Kendrick | RSU | 2025-03-03 | — | — | 2,845 | — | 1,125,198 |
| Peter Haytaian | OPTION | 2025-03-03 | — | — | 11,549 | — | 1,199,710 |
| Gail Boudreaux | OPTION | 2025-03-03 | — | — | 40,429 | — | 4,199,765 |
| Peter Haytaian | RSU | 2025-03-03 | — | — | 3,035 | — | 1,200,343 |
| Mark Kaye | OPTION | 2025-03-03 | — | — | 13,713 | — | 1,424,506 |
| Mark Kaye | RSU | 2025-03-03 | — | — | 3,604 | — | 1,425,382 |
| Felicia Norwood | RSU | 2025-03-03 | — | — | 3,035 | — | 1,200,343 |
| C. Morgan Kendrick | OPTION | 2025-03-03 | — | — | 10,828 | — | 1,124,813 |
| Felicia Norwood | OPTION | 2025-03-03 | — | — | 11,549 | — | 1,199,710 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| C. Morgan Kendrick | $1,125,198 | $2,475,039 | $1,124,813 | 52.4% |
| Felicia Norwood | 1,200,343 | 2,639,963 | 1,199,710 | 52.4% |
| Gail Boudreaux | 4,200,210 | 9,240,067 | 4,199,765 | 52.4% |
| Peter Haytaian | 1,200,343 | 2,639,963 | 1,199,710 | 52.4% |
| Mark Kaye | 1,425,382 | 3,135,129 | 1,424,506 | 52.4% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| C. Morgan Kendrick | Option | 2,596 | 469.03 | — |
| Mark Kaye | Option | 2,692 | 440.19 | — |
| Peter Haytaian | Option | 2,938 | 469.03 | — |
| Felicia Norwood | Option | 2,938 | 469.03 | — |
| C. Morgan Kendrick | Option | 5,542 | 499.11 | — |
| Peter Haytaian | Option | 6,187 | 499.11 | — |
| Felicia Norwood | Option | 6,187 | 499.11 | — |
| Mark Kaye | Option | 7,089 | 499.11 | — |
| C. Morgan Kendrick | RSU | 7,489 | — | 2,625,269 |
| Peter Haytaian | RSU | 8,268 | — | 2,898,347 |
| Felicia Norwood | RSU | 8,268 | — | 2,898,347 |
| C. Morgan Kendrick | PSU | 10,566 | — | 3,703,911 |
| Gail Boudreaux | Option | 10,794 | 469.03 | — |
| C. Morgan Kendrick | Option | 10,828 | 395.5 | — |
| Peter Haytaian | PSU | 11,483 | — | 4,025,366 |
| Felicia Norwood | PSU | 11,483 | — | 4,025,366 |
| Peter Haytaian | Option | 11,549 | 395.5 | — |
| Felicia Norwood | Option | 11,549 | 395.5 | — |
| Mark Kaye | PSU | 13,437 | — | 4,710,340 |
| Mark Kaye | Option | 13,713 | 395.5 | — |
| Mark Kaye | RSU | 14,827 | — | 5,197,605 |
| Gail Boudreaux | Option | 21,654 | 499.11 | — |
| Gail Boudreaux | RSU | 29,565 | — | 10,364,011 |
| Gail Boudreaux | PSU | 40,193 | — | 14,089,656 |
| Gail Boudreaux | Option | 40,429 | 395.5 | — |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Ramiro G. PeruIndependent · Board Chair · Compensation and Talent · Governance | $299,750 | $224,948 | $0 | — | $28,621 | $553,319 |
| Elizabeth E. TallettIndependent · Departed during FY | 144,846 | 0 | 0 | — | 259,515 | 404,361 |
| Ryan M. SchneiderIndependent · Audit (Chair) · Governance | 155,052 | 224,948 | 0 | — | 18,621 | 398,621 |
| Bahija JallalIndependent · Compensation and Talent · Governance (Chair) | 155,052 | 224,948 | 0 | — | 18,621 | 398,621 |
| Antonio F. NeriIndependent · Compensation and Talent (Chair) · Governance | 143,925 | 224,948 | 0 | — | 18,621 | 387,495 |
| Susan D. DeVoreIndependent · Compensation and Talent · Finance (Chair) | 143,925 | 224,948 | 0 | — | 10,000 | 378,874 |
| R. Kerry ClarkIndependent · Audit · Finance · Not standing for re-election | 136,178 | 224,948 | 0 | — | 10,000 | 371,126 |
| Robert L. Dixon JrIndependent · Compensation and Talent · Finance | 125,052 | 224,948 | 0 | — | 18,621 | 368,621 |
| Deanna D. StrableIndependent · Audit · Governance | 125,052 | 224,948 | 0 | — | 10,000 | 360,000 |
| Lewis Hay IIIIndependent · Audit · Finance | 125,052 | 224,948 | 0 | — | 10,000 | 360,000 |
| Steven H. CollisIndependent · Audit · Finance | 52,147 | 175,508 | 0 | — | 10,000 | 237,655 |
| Amy W. SchulmanIndependent · Audit · Finance · Newly elected | 0 | 0 | 0 | — | 0 | 0 |
| Gail K. BoudreauxEmployee director | 0 | 0 | 0 | — | 0 | 0 |
Board fee structure and ownership guideline
| Annual cash retainer | $125,000 |
|---|---|
| Annual equity retainer | $225,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 30,000 / 30,000 / 30,000 |
| Stock ownership guideline | See “Corporate Governance — Board Practices, Processes and Policies — Board Equity Compensation and Stock Ownership Guidelines” for a discussion of our directors’ stock ownership requirements. |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $1,606,031 |
| Equity awards (grant-date value) | $2,200,040 |
| All other compensation | $412,620 |
| Total cost of the board | $4,218,691 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Elevance Health as a peer
Companies that benchmark against ELV
14 companies name ELV as a compensation peer
- Archer-Daniels-Midland CoADMFY2025
- CARDINAL HEALTH INCCAHFY2026
- CENTENE CORPCNCFY2025
- Cigna GroupCIFY2025
- CVS HEALTH CorpCVSFY2025
- FEDEX CORPFDXFY2026
- HCA Healthcare, Inc.HCAFY2025
- HUMANA INCHUMFY2025
- MCKESSON CORPMCKFY2026
- METLIFE INCMETFY2025
- MOLINA HEALTHCARE, INC.MOHFY2025
- PROGRESSIVE CORP/OH/PGRFY2025
- TARGET CORPTGTFY2025
- UNITEDHEALTH GROUP INCUNHFY2025
Each company listed discloses ELV in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named ELV in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Disclosed peer group — fiscal year 2025
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
CVS CVS Health CorporationAMZN Amazon.com, Inc.T AT&T Inc.COR Cencora, Inc.CVX Chevron CorporationF Ford Motor CompanyMS Morgan StanleyPEP PepsiCo, Inc.TGT Target CorporationGS The Goldman Sachs Group, Inc.VLO Valero Energy CorporationVZ Verizon Communications Inc.WBA Walgreens Boots Alliance, Inc.WMT Walmart Inc.MCK McKesson CorporationHD The Home Depot, Inc.LOW Lowe's Companies, Inc.JNJ Johnson & JohnsonPG The Procter & Gamble CompanyBRK.A Berkshire Hathaway Inc.MPC Marathon Petroleum CorporationPSX Phillips 66FNMA Federal National Mortgage AssociationCMCSA Comcast CorporationGOOGL Alphabet Inc.DELL Dell Technologies Inc.FMCC Federal Home Loan Mortgage CorporationJPM JPMorgan Chase & Co.KR The Kroger Co.META Meta Platforms, Inc.UPS United Parcel Service, Inc.DIS The Walt Disney CompanyTSLA Tesla, Inc.CAH Cardinal Health, Inc.MSFT Microsoft CorporationC Citigroup Inc.COST Costco Wholesale CorporationCNC Centene CorporationUNH UnitedHealth Group IncorporatedHUM Humana Inc.
Peer reciprocity
Of the companies Elevance Health names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
CVS Health Corporation (CVS)— Amazon.com, Inc. (AMZN)108— AT&T Inc. (T)109— Cencora, Inc. (COR)110— Chevron Corporation (CVX)111— Ford Motor Company (F)112— Morgan Stanley (MS)113 PepsiCo, Inc. (PEP)✓ Target Corporation (TGT)114— The Goldman Sachs Group, Inc. (GS)115— Valero Energy Corporation (VLO)116— Verizon Communications Inc. (VZ)117— Walgreens Boots Alliance, Inc. (WBA)118— Walmart Inc. (WMT)119 McKesson Corporation (MCK)— The Home Depot, Inc. (HD)120— Lowe's Companies, Inc. (LOW)121— Johnson & Johnson (JNJ)122— The Procter & Gamble Company (PG)123 Berkshire Hathaway Inc. (BRK.A)— Marathon Petroleum Corporation (MPC)124— Phillips 66 (PSX)125 Federal National Mortgage Association (FNMA)— Comcast Corporation (CMCSA)126— Alphabet Inc. (GOOGL)127 Dell Technologies Inc. (DELL) Federal Home Loan Mortgage Corporation (FMCC)— JPMorgan Chase & Co. (JPM)128 The Kroger Co. (KR)— Meta Platforms, Inc. (META)129
Reciprocity shown where the peer’s own current proxy has been read — each mark is cited in the register to that peer’s filing. A dash means the peer’s current proxy was read and names no reciprocal group including Elevance Health.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | The Goldman Sachs Group, Inc. | 2025 | David Solomon | $2,000,000 | $101,177,384 | $0 | $0 | $118,135,674 |
| 2 | JPMorgan Chase & Co. | 2025 | James Dimon | 1,500,000 | 32,500,000 | — | — | 40,632,724 |
| 3 | Morgan Stanley | 2025 | Edward Pick | 1,500,000 | 24,476,463 | 0 | 0 | 37,187,657 |
| 4 | Comcast Corporation | 2025 | Brian Roberts | 2,600,962 | 23,473,076 | 0 | 8,583,175 | 35,148,413 |
| 5 | Verizon Communications Inc. | 2025 | Daniel Schulman | 375,000 | 32,774,795 | 0 | 937,500 | 34,311,016 |
| 6 | Valero Energy Corporation | 2025 | R. Lane Riggs | 1,720,000 | 15,760,536 | 0 | 5,482,810 | 34,228,523 |
| 7 | Johnson & Johnson | 2025 | Joaquin Duato | 1,600,000 | 15,028,948 | 5,927,995 | 4,298,700 | 32,758,111 |
| 8 | AT&T Inc. | 2025 | John Stankey | 2,400,000 | 19,500,012 | 0 | 6,272,000 | 29,906,872 |
| 9 | Walmart Inc. | 2026 | Doug McMillon | 1,500,000 | 21,051,605 | 0 | 4,032,000 | 29,240,930 |
| 10 | Ford Motor Company | 2025 | James Farley Jr. | 1,700,000 | 18,868,309 | 0 | 5,746,000 | 27,519,558 |
| 11 | Chevron Corporation | 2025 | Michael Wirth | 1,900,000 | 13,524,995 | 4,376,640 | 3,562,500 | 26,828,240 |
| 12 | Meta Platforms, Inc. | 2025 | Mark Zuckerberg | 1 | 0 | 0 | 0 | 25,125,904 |
| 13 | McKesson Corporation | 2026 | Brian Tyler | 1,591,667 | 17,201,202 | 0 | 4,456,668 | 24,213,044 |
| 14 | PepsiCo, Inc. | 2025 | Ramon Laguarta | 1,804,615 | 11,550,008 | 0 | 5,771,000 | 23,903,545 |
| 15 | Phillips 66 | 2025 | Mark Lashier | 1,741,667 | 16,185,204 | 0 | 3,734,134 | 23,113,403 |
| 16 | Elevance Health | 2025 | Gail Boudreaux | 1,600,000 | 13,440,277 | 4,199,765 | 2,768,000 | 22,582,314 |
| 17 | Lowe's Companies, Inc. | 2025 | Marvin Ellison | 1,544,231 | 12,480,467 | 4,262,895 | 3,232,693 | 21,581,889 |
| 18 | CVS Health Corporation | 2025 | J. David Joyner | 1,500,000 | 14,499,931 | 0 | 4,695,900 | 21,214,084 |
| 19 | Marathon Petroleum Corporation | 2025 | Maryann Mannen | 1,400,000 | 13,391,322 | 0 | 3,303,300 | 19,016,261 |
| 20 | The Procter & Gamble Company | 2026 | Shailesh Jejurikar | 1,387,500 | 11,035,209 | 3,500,010 | 0 | 18,976,742 |
| 21 | Cencora, Inc. | 2025 | Robert Mauch | 1,350,000 | 12,000,218 | 0 | 4,283,213 | 18,256,227 |
| 22 | The Home Depot, Inc. | 2025 | Edward Decker | 1,400,000 | 9,612,251 | 2,369,917 | 2,657,631 | 16,191,127 |
| 23 | The Kroger Co. | 2025 | Ronald L. Sargent | 3,975,806 | 10,000,077 | — | — | 14,037,608 |
| 24 | Walgreens Boots Alliance, Inc. | 2024 | Timothy Wentworth | 1,290,385 | 11,600,744 | 0 | 0 | 13,282,800 |
| 25 | Alphabet Inc. | 2025 | Sundar Pichai | 2,007,692 | 0 | 0 | 0 | 10,906,079 |
| 26 | Target Corporation | 2025 | Michael Fiddelke | 1,065,385 | 7,853,253 | 0 | 300,882 | 9,598,071 |
| 27 | Dell Technologies Inc. | 2026 | Michael Dell | 950,000 | 0 | 0 | 2,394,000 | 3,382,209 |
| 28 | Amazon.com, Inc. | 2025 | Andrew Jassy | 365,000 | 0 | 0 | 0 | 2,069,861 |
| 29 | Berkshire Hathaway Inc. | 2025 | Warren Buffett | 100,000 | 0 | 0 | 0 | 389,488 |
| — | Federal National Mortgage Association | — | — | — | — | — | — | not in coverage universe |
| — | Federal Home Loan Mortgage Corporation | — | — | — | — | — | — | not in coverage universe |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Elevance Health | 86.5% | PSU 52 · RSU 24 · Options 24 | No | Willis Towers Watson (WTW) |
| Alphabet Inc. | not disclosed | not disclosed | Yes — Alphabet's relative total shareholder return relative to S&P 100 companies (TSR) | Compensia Inc. and Semler Brossy |
| Amazon.com, Inc. | not disclosed | RSU 100 | not disclosed | None (Committee may engage compensation consultants but did not do so in 2025) |
| AT&T Inc. | 112% | PSU 75 · RSU 25 | Yes — Relative Total Stockholder Return (TSR) Payout Modifier | Frederic W. Cook & Co., Inc. (FW Cook) |
| Berkshire Hathaway Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Cencora, Inc. | 181.3% | PSU 60 · RSU 40 | Yes — Relative TSR | Pearl Meyer & Partners |
| Chevron Corporation | 125% | PSU 50 · RSU 25 · Options 25 | Yes — Relative Total Stockholder Return (TSR) | Meridian Compensation Partners, LLC |
| Comcast Corporation | 110% | PSU 100 | Yes — Relative TSR Modifier | Korn Ferry |
| CVS Health Corporation | 156.5% | PSU 60 · RSU 20 · Options 20 | Yes — rTSR Modifier | Korn Ferry |
| Dell Technologies Inc. | 126% | not disclosed | Yes — Relative Total Shareholder Return (rTSR) | Pay Governance |
| Federal Home Loan Mortgage Corporation | not disclosed | not disclosed | not disclosed | not disclosed |
| Federal National Mortgage Association | not disclosed | not disclosed | not disclosed | not disclosed |
| Ford Motor Company | 130% | PSU 60 · RSU 40 | Yes — rTSR (relative Total Shareholder Return) | Not explicitly named in CD&A |
| Johnson & Johnson | not disclosed | not disclosed | Yes — Relative TSR | Semler Brossy Consulting Group |
| JPMorgan Chase & Co. | not disclosed | cash 40 · PSU 30 · RSU 30 | No | not disclosed |
| Lowe's Companies, Inc. | 104.67% | PSU 39 · RSA 30 · Stock Options 20 | No | Semler Brossy Consulting Group, LLC |
| Marathon Petroleum Corporation | 143% | not disclosed | Yes — Relative TSR | FW Cook |
| McKesson Corporation | 140% | PSU 60 · RSU 40 | Yes — Total Shareholder Return (TSR) relative to comparator group | Korn Ferry |
| Meta Platforms, Inc. | 115% | RSU 100 | not disclosed | Compensia, Inc. |
| Morgan Stanley | not disclosed | PSU 100 | No | Semler Brossy |
| PepsiCo, Inc. | not disclosed | not disclosed | Yes — Relative TSR Performance | FW Cook |
| Phillips 66 | 134% | PSU 70 · RSU 30 | Yes — Relative TSR | Mercer |
| Target Corporation | not disclosed | PSU 60 · PBRSU 40 | No | Semler Brossy |
| The Goldman Sachs Group, Inc. | not disclosed | not disclosed | No | Frederic W. Cook & Co., Inc. (FW Cook) |
| The Home Depot, Inc. | 95% | PSU 50 · RSU 30 · Options 20 | No | Pay Governance |
| The Kroger Co. | 93.84% | not disclosed | Yes — Value creation (iTSR) | Korn Ferry; Meridian Compensation Partners, LLC |
| The Procter & Gamble Company | not disclosed | PSU 50 · RSU 25 · Option 25 | Yes — Relative TSR Multiplier | Meridian Compensation Partners, LLC |
| Valero Energy Corporation | 199.23% | PSU 50 · RSU 50 | Yes — Relative TSR | Exequity |
| Verizon Communications Inc. | 100% | PSU 60 · RSU 40 | Yes — relative total shareholder return (TSR) position compared with the companies in the S&P 100 | Meridian Compensation Partners, LLC |
| Walgreens Boots Alliance, Inc. | not disclosed | RSU 100 | not disclosed | Mercer |
| Walmart Inc. | 112% | not disclosed | No | Farient Advisors LLC |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-05-13 | 172,363,616 | 7,240,619 | 199,534 | 95.97% | Passed |
| 2025 | 2025-05-14 | 173,964,580 | 15,522,459 | 238,310 | 91.81% | Passed |
| 2024 | 2024-05-15 | 179,754,212 | 15,863,613 | 656,970 | 91.89% | Passed |
| 2023 | 2023-05-10 | 187,532,307 | 11,449,434 | 665,501 | 94.25% | Passed |
| 2022 | 2022-05-18 | 187,509,042 | 15,306,362 | 744,902 | 92.45% | Passed |
| 2021 | 2021-05-26 | 190,414,081 | 13,239,807 | 296,894 | 93.5% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-05-13 | 95.97%a |
| 2025 | 2025-05-14 | 91.81%b |
| 2024 | 2024-05-15 | 91.89%c |
a. Approved under the standard stated in the filing — “Abstentions will have no effect on the outcome of any proposal.”.
b. Approved under the standard stated in the filing — “Abstentions will have no effect on the outcome of any proposal.”.
c. Approved under the standard stated in the filing — “Abstentions will have no effect on the outcome of any proposal.”.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | 286 : 1 |
|---|---|
| CEO total compensation | $22,582,314 |
| Median employee compensation | $79,007 |
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Steven H. Collis | Director | 2026-05-13 | A | 563 | $0 | $0 | Common | Form 4 ↗ |
| Susan D. DeVore | Director | 2026-05-13 | A | 563 | 0 | 0 | Common | Form 4 ↗ |
| Lewis Hay III | Director | 2026-05-13 | A | 563 | 0 | 0 | Common | Form 4 ↗ |
| Bahija Jallal | Director | 2026-05-13 | A | 563 | 0 | 0 | Common | Form 4 ↗ |
| Ramiro G. Peru | Director | 2026-05-13 | A | 563 | 0 | 0 | Common | Form 4 ↗ |
| Ryan M. Schneider | Director | 2026-05-13 | A | 563 | 0 | 0 | Common | Form 4 ↗ |
| Amy W. Schulman | Director | 2026-05-13 | A | 563 | 0 | 0 | Common | Form 4 ↗ |
| Deanna D. Strable-Soethout | Director | 2026-05-13 | A | 563 | 0 | 0 | Common | Form 4 ↗ |
| Robert L. Dixon Jr | Director | 2026-05-13 | A | 563 | 0 | 0 | Common | Form 4 ↗ |
| Antonio F. Neri | Director | 2026-05-13 | A | 563 | 0 | 0 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-05-19 | — | 1,531 | — | — | 1 insider, 2 accrual rows | ||
| Ronald W. Penczek | CAO & Controller | 2026-05-19 | D | 1,531 | 403 | 617,192 | Common | Form 4 ↗ |
| Ronald W. Penczek | CAO & Controller | 2026-05-19 | A | 654 | 271 | 177,411 | Common | Form 4 ↗ |
| Ronald W. Penczek | CAO & Controller | 2026-05-19 | A | 877 | 311 | 273,168 | Common | Form 4 ↗ |
| Robert L. Dixon Jr | Director | 2026-06-11 | D | 151 | 402 | 60,667 | Common | Form 4 ↗ |
| Ronald W. Penczek | CAO & Controller | 2026-06-12 | D | 369 | 403 | 148,766 | Common, open-market sale | Form 4 ↗ |
| Gail Boudreaux | Director | 2026-07-17 | A | 2,045 | 368 | 753,071 | Common | Form 4 ↗ |
| Gail Boudreaux | Director | 2026-07-17 | A | 680 | 366 | 249,159 | Common | Form 4 ↗ |
| Ramiro G. Peru | Director | 2026-07-17 | A | 1,000 | 366 | 366,050 | Common | Form 4 ↗ |
| Erin M. Wessling | EVP & Chief Legal Officer | 2026-09-02 | D | 94 | 406 | 38,149 | Common | Form 4 ↗ |
| Ryan R. Craig | EVP & Chief HR Officer | 2026-09-02 | D | 144 | 406 | 58,441 | Common | Form 4 ↗ |
| Erin M. Wessling | EVP & Chief Legal Officer | 2026-09-03 | D | 255 | 415 | 105,769 | Common | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-02 | D | 4,161 | 386 | 1,607,935 | Common | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-02 | A | 2,627 | 0 | 0 | Common | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-22 | D | 827 | 446 | 368,883 | Common, open-market sale | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-22 | D | 160 | 445 | 71,176 | Common, open-market sale | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-22 | D | 440 | 444 | 195,276 | Common, open-market sale | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-22 | D | 480 | 443 | 212,453 | Common, open-market sale | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-22 | D | 2,343 | 441 | 1,034,060 | Common, open-market sale | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-22 | D | 1,720 | 440 | 757,557 | Common, open-market sale | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-22 | D | 1,160 | 439 | 509,530 | Common, open-market sale | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-22 | D | 240 | 438 | 105,173 | Common, open-market sale | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-22 | D | 560 | 437 | 244,759 | Common, open-market sale | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-22 | D | 1,660 | 436 | 724,092 | Common, open-market sale | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-22 | D | 321 | 435 | 139,715 | Common, open-market sale | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-22 | D | 400 | 434 | 173,600 | Common, open-market sale | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-22 | D | 273 | 447 | 122,083 | Common, open-market sale | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
View all 38 transactions
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Steven H. Collis | Director | 2026-05-13 | A | 563 | $0 | $0 | Common | Form 4 ↗ |
| Susan D. DeVore | Director | 2026-05-13 | A | 563 | 0 | 0 | Common | Form 4 ↗ |
| Lewis Hay III | Director | 2026-05-13 | A | 563 | 0 | 0 | Common | Form 4 ↗ |
| Bahija Jallal | Director | 2026-05-13 | A | 563 | 0 | 0 | Common | Form 4 ↗ |
| Ramiro G. Peru | Director | 2026-05-13 | A | 563 | 0 | 0 | Common | Form 4 ↗ |
| Ryan M. Schneider | Director | 2026-05-13 | A | 563 | 0 | 0 | Common | Form 4 ↗ |
| Amy W. Schulman | Director | 2026-05-13 | A | 563 | 0 | 0 | Common | Form 4 ↗ |
| Deanna D. Strable-Soethout | Director | 2026-05-13 | A | 563 | 0 | 0 | Common | Form 4 ↗ |
| Robert L. Dixon Jr | Director | 2026-05-13 | A | 563 | 0 | 0 | Common | Form 4 ↗ |
| Antonio F. Neri | Director | 2026-05-13 | A | 563 | 0 | 0 | Common | Form 4 ↗ |
| Ronald W. Penczek | CAO & Controller | 2026-05-19 | D | 877 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Ronald W. Penczek | CAO & Controller | 2026-05-19 | D | 654 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Ronald W. Penczek | CAO & Controller | 2026-05-19 | D | 1,531 | 403 | 617,192 | Common | Form 4 ↗ |
| Ronald W. Penczek | CAO & Controller | 2026-05-19 | A | 654 | 271 | 177,411 | Common | Form 4 ↗ |
| Ronald W. Penczek | CAO & Controller | 2026-05-19 | A | 877 | 311 | 273,168 | Common | Form 4 ↗ |
| Robert L. Dixon Jr | Director | 2026-06-11 | D | 151 | 402 | 60,667 | Common | Form 4 ↗ |
| Ronald W. Penczek | CAO & Controller | 2026-06-12 | D | 369 | 403 | 148,766 | Common, open-market sale | Form 4 ↗ |
| Gail Boudreaux | Director | 2026-07-17 | A | 2,045 | 368 | 753,071 | Common | Form 4 ↗ |
| Gail Boudreaux | Director | 2026-07-17 | A | 680 | 366 | 249,159 | Common | Form 4 ↗ |
| Ramiro G. Peru | Director | 2026-07-17 | A | 1,000 | 366 | 366,050 | Common | Form 4 ↗ |
| Erin M. Wessling | EVP & Chief Legal Officer | 2026-09-02 | D | 94 | 406 | 38,149 | Common | Form 4 ↗ |
| Ryan R. Craig | EVP & Chief HR Officer | 2026-09-02 | D | 144 | 406 | 58,441 | Common | Form 4 ↗ |
| Erin M. Wessling | EVP & Chief Legal Officer | 2026-09-03 | D | 255 | 415 | 105,769 | Common | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-02 | D | 4,161 | 386 | 1,607,935 | Common | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-02 | A | 2,627 | 0 | 0 | Common | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-22 | D | 827 | 446 | 368,883 | Common, open-market sale | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-22 | D | 160 | 445 | 71,176 | Common, open-market sale | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-22 | D | 440 | 444 | 195,276 | Common, open-market sale | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-22 | D | 480 | 443 | 212,453 | Common, open-market sale | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-22 | D | 2,343 | 441 | 1,034,060 | Common, open-market sale | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-22 | D | 1,720 | 440 | 757,557 | Common, open-market sale | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-22 | D | 1,160 | 439 | 509,530 | Common, open-market sale | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-22 | D | 240 | 438 | 105,173 | Common, open-market sale | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-22 | D | 560 | 437 | 244,759 | Common, open-market sale | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-22 | D | 1,660 | 436 | 724,092 | Common, open-market sale | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-22 | D | 321 | 435 | 139,715 | Common, open-market sale | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-22 | D | 400 | 434 | 173,600 | Common, open-market sale | Form 4 ↗ |
| Mark Kaye | EVP & CFO | 2026-10-22 | D | 273 | 447 | 122,083 | Common, open-market sale | Form 4 ↗ |
Sources (129 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Gail Boudreaux. DEF 14A, filed 2026-03-27. Section “Summary Compensation Table” · page 58. As printed: 22,582,314. View filing ↗
- Section 01, Mark Kaye. DEF 14A, filed 2026-03-27. Section “Summary Compensation Table” · page 58. As printed: 7,992,077. View filing ↗
- Section 01, Peter Haytaian. DEF 14A, filed 2026-03-27. Section “Summary Compensation Table” · page 58. As printed: 7,098,488. View filing ↗
- Section 01, Felicia Norwood. DEF 14A, filed 2026-03-27. Section “Summary Compensation Table” · page 58. As printed: 7,073,965. View filing ↗
- Section 01, C. Morgan Kendrick. DEF 14A, filed 2026-03-27. Section “Summary Compensation Table” · page 58. As printed: 6,661,911. View filing ↗
- Section 03, C. Morgan Kendrick PSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Felicia Norwood PSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Gail Boudreaux PSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Peter Haytaian PSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Mark Kaye PSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Gail Boudreaux RSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, C. Morgan Kendrick RSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Peter Haytaian OPTION. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Gail Boudreaux OPTION. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Peter Haytaian RSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Mark Kaye OPTION. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Mark Kaye RSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Felicia Norwood RSU. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, C. Morgan Kendrick OPTION. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Felicia Norwood OPTION. DEF 14A, filed 2026-03-27. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2026-03-27. Section “CEO Pay Ratio”. As printed: 286 : 1. View filing ↗
- Section 08, Ramiro G. Peru. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 553,319. View filing ↗
- Section 08, Elizabeth E. Tallett. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 404,361. View filing ↗
- Section 08, Ryan M. Schneider. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 398,621. View filing ↗
- Section 08, Bahija Jallal. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 398,621. View filing ↗
- Section 08, Antonio F. Neri. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 387,495. View filing ↗
- Section 08, Susan D. DeVore. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 378,874. View filing ↗
- Section 08, R. Kerry Clark. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 371,126. View filing ↗
- Section 08, Robert L. Dixon Jr. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 368,621. View filing ↗
- Section 08, Deanna D. Strable. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 360,000. View filing ↗
- Section 08, Lewis Hay III. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 360,000. View filing ↗
- Section 08, Steven H. Collis. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 237,655. View filing ↗
- Section 08, Amy W. Schulman. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Gail K. Boudreaux. DEF 14A, filed 2026-03-27. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 02, Steven H. Collis 2026-05-13. Form 4, filed 2026-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Susan D. DeVore 2026-05-13. Form 4, filed 2026-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lewis Hay III 2026-05-13. Form 4, filed 2026-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bahija Jallal 2026-05-13. Form 4, filed 2026-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ramiro G. Peru 2026-05-13. Form 4, filed 2026-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ryan M. Schneider 2026-05-13. Form 4, filed 2026-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Amy W. Schulman 2026-05-13. Form 4, filed 2026-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Deanna D. Strable-Soethout 2026-05-13. Form 4, filed 2026-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert L. Dixon Jr 2026-05-13. Form 4, filed 2026-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Antonio F. Neri 2026-05-13. Form 4, filed 2026-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ronald W. Penczek 2026-05-19. Form 4, filed 2026-05-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ronald W. Penczek 2026-05-19. Form 4, filed 2026-05-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ronald W. Penczek 2026-05-19. Form 4, filed 2026-05-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ronald W. Penczek 2026-05-19. Form 4, filed 2026-05-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ronald W. Penczek 2026-05-19. Form 4, filed 2026-05-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert L. Dixon Jr 2026-06-11. Form 4, filed 2026-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ronald W. Penczek 2026-06-12. Form 4, filed 2026-06-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Gail Boudreaux 2026-07-17. Form 4, filed 2026-07-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Gail Boudreaux 2026-07-17. Form 4, filed 2026-07-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ramiro G. Peru 2026-07-17. Form 4, filed 2026-07-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Erin M. Wessling 2026-09-02. Form 4, filed 2026-09-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ryan R. Craig 2026-09-02. Form 4, filed 2026-09-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Erin M. Wessling 2026-09-03. Form 4, filed 2026-09-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Kaye 2026-10-02. Form 4, filed 2026-10-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Kaye 2026-10-02. Form 4, filed 2026-10-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Kaye 2026-10-22. Form 4, filed 2026-10-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Kaye 2026-10-22. Form 4, filed 2026-10-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Kaye 2026-10-22. Form 4, filed 2026-10-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Kaye 2026-10-22. Form 4, filed 2026-10-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Kaye 2026-10-22. Form 4, filed 2026-10-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Kaye 2026-10-22. Form 4, filed 2026-10-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Kaye 2026-10-22. Form 4, filed 2026-10-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Kaye 2026-10-22. Form 4, filed 2026-10-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Kaye 2026-10-22. Form 4, filed 2026-10-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Kaye 2026-10-22. Form 4, filed 2026-10-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Kaye 2026-10-22. Form 4, filed 2026-10-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Kaye 2026-10-22. Form 4, filed 2026-10-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Kaye 2026-10-22. Form 4, filed 2026-10-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-05-13. Item 5.07 · say-on-pay result. As reported: 95.97% (votes for as printed: 172,363,616). View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-05-14. Item 5.07 · say-on-pay result. As reported: 91.81% (votes for as printed: 173,964,580). View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-05-15. Item 5.07 · say-on-pay result. As reported: 91.89% (votes for as printed: 179,754,212). View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 1,606,031 + equity 2,200,040 + all other 412,620 = 4,218,691, summed across the director compensation table rows.
- The Goldman Sachs Group, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-20. CEO total compensation as printed in The Goldman Sachs Group, Inc.'s own proxy. As printed: 118,135,674. View filing ↗
- JPMorgan Chase & Co., Section 10b CEO total. DEF 14A, filed 2026-04-06. CEO total compensation as printed in JPMorgan Chase & Co.'s own proxy. As printed: 40,632,724. View filing ↗
- Morgan Stanley, Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in Morgan Stanley's own proxy. As printed: 37,187,657. View filing ↗
- Comcast Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-24. CEO total compensation as printed in Comcast Corporation's own proxy. As printed: 35,148,413. View filing ↗
- Verizon Communications Inc., Section 10b CEO total. DEF 14A, filed 2026-04-06. CEO total compensation as printed in Verizon Communications Inc.'s own proxy. As printed: 34,311,016. View filing ↗
- Valero Energy Corporation, Section 10b CEO total. DEF 14A, filed 2026-03-19. CEO total compensation as printed in Valero Energy Corporation's own proxy. As printed: 34,228,523. View filing ↗
- Johnson & Johnson, Section 10b CEO total. DEF 14A, filed 2026-03-11. CEO total compensation as printed in Johnson & Johnson's own proxy. As printed: 32,758,111. View filing ↗
- AT&T Inc., Section 10b CEO total. DEF 14A, filed 2026-03-23. CEO total compensation as printed in AT&T Inc.'s own proxy. As printed: 29,906,872. View filing ↗
- Walmart Inc., Section 10b CEO total. DEF 14A, filed 2026-04-23. CEO total compensation as printed in Walmart Inc.'s own proxy. As printed: 29,240,930. View filing ↗
- Ford Motor Company, Section 10b CEO total. DEF 14A, filed 2026-03-27. CEO total compensation as printed in Ford Motor Company's own proxy. As printed: 27,519,558. View filing ↗
- Chevron Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-07. CEO total compensation as printed in Chevron Corporation's own proxy. As printed: 26,828,240. View filing ↗
- Meta Platforms, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-16. CEO total compensation as printed in Meta Platforms, Inc.'s own proxy. As printed: 25,125,904. View filing ↗
- McKesson Corporation, Section 10b CEO total. DEF 14A, filed 2026-06-12. CEO total compensation as printed in McKesson Corporation's own proxy. As printed: 24,213,044. View filing ↗
- PepsiCo, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-27. CEO total compensation as printed in PepsiCo, Inc.'s own proxy. As printed: 23,903,545. View filing ↗
- Phillips 66, Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in Phillips 66's own proxy. As printed: 23,113,403. View filing ↗
- Elevance Health (subject), Section 10b CEO total. DEF 14A, filed 2026-03-27. CEO total compensation as printed in Elevance Health's own proxy. As printed: 22,582,314. View filing ↗
- Lowe's Companies, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-16. CEO total compensation as printed in Lowe's Companies, Inc.'s own proxy. As printed: 21,581,889. View filing ↗
- CVS Health Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-03. CEO total compensation as printed in CVS Health Corporation's own proxy. As printed: 21,214,084. View filing ↗
- Marathon Petroleum Corporation, Section 10b CEO total. DEF 14A, filed 2026-03-16. CEO total compensation as printed in Marathon Petroleum Corporation's own proxy. As printed: 19,016,261. View filing ↗
- The Procter & Gamble Company, Section 10b CEO total. DEF 14A, filed 2026-08-28. CEO total compensation as printed in The Procter & Gamble Company's own proxy. As printed: 18,976,742. View filing ↗
- Cencora, Inc., Section 10b CEO total. DEF 14A, filed 2026-01-22. CEO total compensation as printed in Cencora, Inc.'s own proxy. As printed: 18,256,227. View filing ↗
- The Home Depot, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-07. CEO total compensation as printed in The Home Depot, Inc.'s own proxy. As printed: 16,191,127. View filing ↗
- The Kroger Co., Section 10b CEO total. DEF 14A, filed 2026-05-13. CEO total compensation as printed in The Kroger Co.'s own proxy. As printed: 14,037,608. View filing ↗
- Walgreens Boots Alliance, Inc., Section 10b CEO total. DEF 14A, filed 2024-12-13. CEO total compensation as printed in Walgreens Boots Alliance, Inc.'s own proxy. As printed: 13,282,800. View filing ↗
- Alphabet Inc., Section 10b CEO total. DEF 14A, filed 2026-04-24. CEO total compensation as printed in Alphabet Inc.'s own proxy. As printed: 10,906,079. View filing ↗
- Target Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-27. CEO total compensation as printed in Target Corporation's own proxy. As printed: 9,598,071. View filing ↗
- Dell Technologies Inc., Section 10b CEO total. DEF 14A, filed 2026-05-15. CEO total compensation as printed in Dell Technologies Inc.'s own proxy. As printed: 3,382,209. View filing ↗
- Amazon.com, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-09. CEO total compensation as printed in Amazon.com, Inc.'s own proxy. As printed: 2,069,861. View filing ↗
- Berkshire Hathaway Inc., Section 10b CEO total. DEF 14A, filed 2026-03-13. CEO total compensation as printed in Berkshire Hathaway Inc.'s own proxy. As printed: 389,488. View filing ↗
- Section 10a, Amazon.com, Inc. reciprocity. DEF 14A. Amazon.com, Inc.'s most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗
- Section 10a, AT&T Inc. reciprocity. DEF 14A. AT&T Inc.'s most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗
- Section 10a, Cencora, Inc. reciprocity. DEF 14A. Cencora, Inc.'s most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗
- Section 10a, Chevron Corporation reciprocity. DEF 14A. Chevron Corporation's most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗
- Section 10a, Ford Motor Company reciprocity. DEF 14A. Ford Motor Company's most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗
- Section 10a, Morgan Stanley reciprocity. DEF 14A. Morgan Stanley's most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗
- Section 10a, Target Corporation reciprocity. DEF 14A. Target Corporation names Elevance Health in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, The Goldman Sachs Group, Inc. reciprocity. DEF 14A. The Goldman Sachs Group, Inc.'s most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗
- Section 10a, Valero Energy Corporation reciprocity. DEF 14A. Valero Energy Corporation's most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗
- Section 10a, Verizon Communications Inc. reciprocity. DEF 14A. Verizon Communications Inc.'s most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗
- Section 10a, Walgreens Boots Alliance, Inc. reciprocity. DEF 14A. Walgreens Boots Alliance, Inc.'s most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗
- Section 10a, Walmart Inc. reciprocity. DEF 14A. Walmart Inc.'s most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗
- Section 10a, The Home Depot, Inc. reciprocity. DEF 14A. The Home Depot, Inc.'s most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗
- Section 10a, Lowe's Companies, Inc. reciprocity. DEF 14A. Lowe's Companies, Inc.'s most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗
- Section 10a, Johnson & Johnson reciprocity. DEF 14A. Johnson & Johnson's most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗
- Section 10a, The Procter & Gamble Company reciprocity. DEF 14A. The Procter & Gamble Company's most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗
- Section 10a, Marathon Petroleum Corporation reciprocity. DEF 14A. Marathon Petroleum Corporation's most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗
- Section 10a, Phillips 66 reciprocity. DEF 14A. Phillips 66's most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗
- Section 10a, Comcast Corporation reciprocity. DEF 14A. Comcast Corporation's most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗
- Section 10a, Alphabet Inc. reciprocity. DEF 14A. Alphabet Inc.'s most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗
- Section 10a, JPMorgan Chase & Co. reciprocity. DEF 14A. JPMorgan Chase & Co.'s most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗
- Section 10a, Meta Platforms, Inc. reciprocity. DEF 14A. Meta Platforms, Inc.'s most recent proxy was read; its disclosed peer group does not include Elevance Health. View filing ↗